CD200 and neoplasm: Studies reported above (Fig 5B) show that there is indeed an additive protective effect on long term anti-tumor immunity seen in CD200-/- mice following combination of the immunotherapeutic approach used before, with daily metformin administration beginning following immunotherapy.